Keyphrases
Rate Ratio
100%
Hazard Rate
100%
Schizophrenia Spectrum Disorders
100%
Psychosis
66%
Clinical High Risk for Psychosis (CHR-P)
66%
Asthma
66%
Somatic Symptoms
66%
Active Comparator
66%
Anti-inflammatory Properties
33%
Large-scale Longitudinal Study
33%
Acute Psychosis
33%
Systemic Glucocorticoids
33%
Schizophrenia
33%
Potential Side Effects
33%
Glucocorticoid Therapy
33%
Beneficial Effects
33%
Clinical Trials
33%
Protective Effect
33%
Psychotic Disorders
33%
Urbanization
33%
Cox Regression
33%
Non-systemic
33%
Psychotic Symptoms
33%
Dose-response Relationship
33%
First Year
33%
Early-onset Schizophrenia
33%
Older Cohort
33%
Parental Education Level
33%
Denmark
33%
Psychiatric History
33%
Pharmacology, Toxicology and Pharmaceutical Science
Glucocorticoid
100%
Schizophrenia Spectrum Disorder
100%
Diseases
22%
Asthma
22%
Anti-Inflammatory Drug
11%
Side Effect
11%
Psychosis
11%
Clinical Trial
11%